Study: Biomarker in urine may offer noninvasive detection of prostate cancer

A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene. This unique biomarker can be detected in the urine samples of patients with prostate cancer, offering a non-invasive means of detection.

From http://besthealthnews.com/2019/10/study-biomarker-in-urine-may-offer-noninvasive-detection-of-prostate-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=study-biomarker-in-urine-may-offer-noninvasive-detection-of-prostate-cancer

from
https://healthnews010.wordpress.com/2019/10/03/study-biomarker-in-urine-may-offer-noninvasive-detection-of-prostate-cancer/

from https://aubreyflores.blogspot.com/2019/10/study-biomarker-in-urine-may-offer.html

from
https://aubreyflores1.tumblr.com/post/188100513384